CORILIEF DRY COUGH SYRUP
HYDROBROMIDE
What it does
Hydrobromide is a medication used to treat various conditions, often related to respiratory issues.
Commonly used for: coughs, asthma, allergic reactions
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Medicines Control Authority of Zimbabwe · fetched 2026-04-18 08:22:06 · updated 2026-09-30 04:30:04
About this medicine
Hydrobromide is a medication used to treat various conditions, often related to respiratory issues.
What it treats
- coughs
- asthma
- allergic reactions
How it works
Hydrobromide works by relaxing the muscles in the airways, making it easier to breathe.
Who it's for
It is suitable for adults and children with respiratory problems or allergies.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: hydrobromide
BNF-referencedHydrobromide refers to a chemical compound formed when hydrobromic acid reacts with an organic base. It is commonly associated with various drugs that are administered in hydrobromide salt form. These salts enhance the stability and solubility of the active pharmaceutical ingredients. The hydrobromide salts are often used in formulations for their pharmacological effects, particularly in the central nervous system and respiratory conditions.
Indications
- Respiratory conditions (e.g., asthma, chronic obstructive pulmonary disease)
- Cough (e.g., as an antitussive)
- Anxiety and sleep disorders (when associated with specific formulations)
Dosage
Children: Refer to the BNF for Children for appropriate dosing information, as it is determined based on weight and age for the specific formulation.
Adults: Refer to the specific product monograph for dosing information, as it varies based on the drug formulation and indication.
Mechanism of action
Hydrobromides often act as competitive antagonists or agonists at specific receptor sites, depending on the drug involved. The exact mechanism can vary widely, but many hydrobromide-containing drugs modulate neurotransmitter activity, impacting various pathways in the body such as those involved in the central nervous system or respiratory function. The metabolic pathways include Phase I reactions primarily mediated by cytochrome P450 enzymes, which facilitate the functionalization and clearance of these compounds.
Pharmacodynamics
The pharmacodynamics of hydrobromide salts are largely determined by the specific drug they are associated with. Generally, hydrobromides may exhibit effects such as sedation, bronchodilation, or antitussive actions. The efficacy and adverse effects are influenced by the drug's receptor selectivity, affinity, and the pharmacological properties inherent to the parent compound.
Pharmacokinetics
Hydrobromides typically exhibit variable pharmacokinetic profiles depending on the specific drug formulation. They are generally absorbed rapidly following oral administration, with peak plasma concentrations occurring within a few hours. Metabolism primarily occurs in the liver through cytochrome P450 enzymes, particularly CYP2E1, among others. The elimination half-life varies but is often in the range of several hours, allowing for once or twice-daily dosing in many formulations. Excretion is usually via the kidneys, with metabolites being eliminated in urine.
Pregnancy
There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefits justify the potential risks to the fetus.
Breast-feeding
Caution is advised; consider the importance of the drug to the mother against potential risks to the breastfeeding infant.
Storage
Store in a cool, dry place away from light. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: hydrobromide
PubChem CID 260Molecular formula: BrH
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- ASCORIL-D · Glenmark Pharmaceuticals
- BENYLIN DMD DECONGESTANT COUGH SRYUP · Surgipharm
- BENYLIN DRY COUGH · Surgipharm
- BEROTEC SYRUP · Boehringer Ingelheim
- CHERICOF COUGH FORMULA · Sun Pharma
- CIPRAM 20MG TABLETS · Phillips Therapeutics
- ADULT BEDIKOF SYRUP · Enicar Pharmaceuticals
- BENYLIN DRY COUGH SYRUP · Johnson & Johnson
- BLUKOF ADULT DRY COUGH SYRUP · Prowill Pharmaceuticals
- BLUKOF CHILDREN DRY COUGH · Prowill Pharmaceuticals
- CHILD BEDIKOF COUGH · Enicar Pharmaceuticals
- CHILD CARE NIGHT REST COUGH AND COLD SYRUP · Letap Pharmaceuticals
- 4-CS COMBINATION PRODUCT SYRUP
- BENYLIN-DRY-COUGH 15MG/5ML SYRUP
- BENYLIN-DRY-COUGH 15MG/5ML SYRUP
- BETACO 15MG/5ML CLEAR RED -SYRUP
- BETAFED COMBINATION PRODUCT CLEAR ORANGE SYRUP
- COFF-EX 5MG/5ML SYRUP